DYN
Price
$18.62
Change
+$0.55 (+3.04%)
Updated
Nov 9 closing price
Capitalization
3.37B
114 days until earnings call
Intraday BUY SELL Signals
MNPR
Price
$73.75
Change
+$2.33 (+3.26%)
Updated
Nov 9 closing price
Capitalization
479.38M
2 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

DYN vs MNPR

DYN vs MNPR Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
DYN vs. MNPR commentary
Nov 10, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DYN is a Hold and MNPR is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for DYN with price predictions
Nov 09, 2026

DYN in upward trend: price rose above 50-day moving average on November 06, 2026

DYN moved above its 50-day moving average on November 06, 2026 date and that indicates a change from a downward trend to an upward trend. In 25 of 29 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 86%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 27, 2026. You may want to consider a long position or call options on DYN as a result. In 61 of 75 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 81%.

Following a +7.26% 3-day Advance, the price is estimated to grow further. Considering data from situations where DYN advanced for three days, in 237 of 282 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.

DYN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The 10-day RSI Indicator for DYN moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 similar instances where the indicator moved out of overbought territory. In 29 of the 38 cases, the stock moved lower in the following days. This puts the odds of a move lower at 76%.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 9 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The 50-day moving average for DYN moved below the 200-day moving average on October 26, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where DYN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.

The Aroon Indicator for DYN entered a downward trend on October 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 20 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 42 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.806) is normal, around the industry mean (3.498). P/E Ratio (-5.543) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (440.869).

The Tickeron Price Growth Rating for this company is 56 (best 1 - 100 worst), indicating steady price growth. DYN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 92 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DYN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock better than average.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
a Summary for MNPR with price predictions
Nov 09, 2026

MNPR in -7.83% downward trend, sliding for three consecutive days on November 02, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where MNPR declined for three days, in 291 of 323 cases, the price declined further within the following month. The odds of a continued downward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Aroon Indicator for MNPR entered a downward trend on November 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where MNPR's RSI Indicator exited the oversold zone, 25 of 30 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 57 of 70 cases where MNPR's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.

The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on MNPR as a result. In 70 of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 82%.

The Moving Average Convergence Divergence (MACD) for MNPR just turned positive on October 20, 2026. Looking at past instances where MNPR's MACD turned positive, the stock continued to rise in 36 of 44 cases over the following month. The odds of a continued upward trend are 82%.

Following a +9.71% 3-day Advance, the price is estimated to grow further. Considering data from situations where MNPR advanced for three days, in 223 of 266 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.

MNPR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 6 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.663) is normal, around the industry mean (3.498). P/E Ratio (-32.464) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (440.869).

The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 49 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating steady price growth. MNPR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 95 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

FUNDAMENTALS RATINGS
DYN vs MNPR: Fundamental Ratings
DYN
MNPR
OUTLOOK RATING
1..100
4012
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
6
Undervalued
PROFIT vs RISK RATING
1..100
9249
SMR RATING
1..100
9895
PRICE GROWTH RATING
1..100
5663
P/E GROWTH RATING
1..100
2014
SEASONALITY SCORE
1..100
n/a29

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MNPR's Valuation (6) in the null industry is somewhat better than the same rating for DYN (42) in the Electric Utilities industry. This means that MNPR’s stock grew somewhat faster than DYN’s over the last 12 months.

MNPR's Profit vs Risk Rating (49) in the null industry is somewhat better than the same rating for DYN (92) in the Electric Utilities industry. This means that MNPR’s stock grew somewhat faster than DYN’s over the last 12 months.

MNPR's SMR Rating (95) in the null industry is in the same range as DYN (98) in the Electric Utilities industry. This means that MNPR’s stock grew similarly to DYN’s over the last 12 months.

DYN's Price Growth Rating (56) in the Electric Utilities industry is in the same range as MNPR (63) in the null industry. This means that DYN’s stock grew similarly to MNPR’s over the last 12 months.

MNPR's P/E Growth Rating (14) in the null industry is in the same range as DYN (20) in the Electric Utilities industry. This means that MNPR’s stock grew similarly to DYN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DYNMNPR
RSI
ODDS (%)
Bearish Trend 1 day ago
76%
Bullish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
78%
Bullish Trend 1 day ago
81%
Momentum
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
82%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
84%
Declines
ODDS (%)
Bearish Trend 18 days ago
86%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
88%
Aroon
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 1 day ago
90%
COMPARISON
Comparison
Nov 10, 2026
Stock price -- (DYN: $18.07 vs. MNPR: $71.42)
Brand notoriety: DYN and MNPR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DYN: 70% vs. MNPR: 44%
Market capitalization -- DYN: $3.37B vs. MNPR: $479.38M
DYN [@Biotechnology] is valued at $3.37B. MNPR’s [@Biotechnology] market capitalization is $479.38M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $138.67B. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DYN’s FA Score shows that 1 FA rating(s) are green while MNPR’s FA Score has 2 green FA rating(s).

  • DYN’s FA Score: 1 green, 4 red.
  • MNPR’s FA Score: 2 green, 3 red.
According to our system of comparison, MNPR is a better buy in the long-term than DYN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DYN’s TA Score shows that 4 TA indicator(s) are bullish while MNPR’s TA Score has 6 bullish TA indicator(s).

  • DYN’s TA Score: 4 bullish, 5 bearish.
  • MNPR’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, MNPR is a better buy in the short-term than DYN.

Price Growth

DYN (@Biotechnology) experienced а +8.27% price change this week, while MNPR (@Biotechnology) price change was +1.56% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.97%. For the same industry, the average monthly price growth was -8.33%, and the average quarterly price growth was +85.08%.

Reported Earning Dates

DYN is expected to report earnings on Mar 04, 2027.

MNPR is expected to report earnings on Nov 12, 2026.

Industries' Descriptions

@Biotechnology (+2.97% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

DYN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DYN has been loosely correlated with RNA. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if DYN jumps, then RNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DYN
1D Price
Change %
DYN100%
+3.04%
RNA - DYN
64%
Loosely correlated
+0.48%
STOK - DYN
53%
Loosely correlated
+4.41%
CLDX - DYN
52%
Loosely correlated
+4.59%
MGTX - DYN
49%
Loosely correlated
+5.44%
SLDB - DYN
49%
Loosely correlated
+6.53%
More

MNPR and

Correlation & Price change

A.I.dvisor indicates that over the last year, MNPR has been loosely correlated with GLUE. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if MNPR jumps, then GLUE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MNPR
1D Price
Change %
MNPR100%
+3.26%
GLUE - MNPR
39%
Loosely correlated
+0.09%
DYN - MNPR
39%
Loosely correlated
+3.04%
IMVT - MNPR
39%
Loosely correlated
+15.13%
SVRA - MNPR
38%
Loosely correlated
+4.55%
VIR - MNPR
38%
Loosely correlated
+11.75%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MEI12.131.37
+12.73%
Methode Electronics
CTOR0.550.04
+7.85%
Citius Oncology Inc
ETOR23.320.35
+1.52%
Etoro Group Ltd
KRYS303.062.18
+0.72%
Krystal Biotech
BANFP26.150.05
+0.19%
BancFirst Corp